IRADIMED CORPORATION Announces Executive Transition

Rhea-AI Summary

IRADIMED CORPORATION (NASDAQ: IRMD) announced the resignation of Chris Scott, the Chief Financial and Operating Officer, effective May 27, 2022. Scott has been with the company since December 2013 and is leaving to pursue other opportunities. Matt Garner, the Controller, will take on the role of interim CFO during the transition. CEO Roger Susi expressed gratitude for Scott's contributions over the years and confidence in Garner's ability to lead the finance department. A formal search for a new CFO is underway.

Positive

• Matt Garner appointed as interim CFO, providing continuity during transition.
• Roger Susi expressed confidence in the finance team's robustness.

Negative

• Resignation of a key executive may lead to uncertainty in financial leadership.
• Potential disruption during the search for a permanent CFO.

WINTER SPRINGS, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has resigned from the Company effective May 27, 2022. Mr. Scott started at the Company in December 2013 and is departing to pursue other opportunities.

A formal search for a new CFO has commenced. The Company has appointed Matt Garner, Controller, to the additional role of interim CFO with immediate effect through the transition period.

“Chris has been a valued partner over the past eight years. Though he will be missed, he leaves us with a sound finance department. Matt has also been with us for just over eight years and is well prepared to step in as interim CFO with Chris providing maximum support during the 30-day transition period,” said Roger Susi, President and Chief Executive Officer of the Company.

About IRADIMED CORPORATION

IRADIMED CORPORATION is a leader in the development of innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices. We develop, manufacture, market and distribute MRI compatible medical devices and accessories, disposables and services relating to them. To learn more about IRADIMED, visit www.iradimed.com.

Media Contact:
InvestorRelations@iradimed.com

FAQ

Who resigned from IRADIMED Corporation on April 28, 2022?

Chris Scott, the Chief Financial and Operating Officer, resigned effective May 27, 2022.

Who will serve as interim CFO for IRADIMED Corporation?

Matt Garner, the Controller, has been appointed as interim CFO.

Why did Chris Scott resign from IRADIMED Corporation?

Chris Scott resigned to pursue other opportunities.

What is the timeline for finding a new CFO at IRADIMED Corporation?

A formal search for a new CFO has commenced following Scott's resignation.